129 related articles for article (PubMed ID: 34010008)
1. Self-Adjuvant Effect by Manipulating the Bionano Interface of Liposome-Based Nanovaccines.
Jiang Z; Liu J; Guan J; Wang H; Ding T; Qian J; Zhan C
Nano Lett; 2021 Jun; 21(11):4744-4752. PubMed ID: 34010008
[TBL] [Abstract][Full Text] [Related]
2. A natural IgM hitchhiking strategy for delivery of cancer nanovaccines to splenic marginal zone B cells.
Wang H; Wu X; Sun Y; Liu A; He Y; Xu Z; Lu Y; Zhan C
J Control Release; 2024 Apr; 368():208-218. PubMed ID: 38395156
[TBL] [Abstract][Full Text] [Related]
3. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.
Guo L; Chen J; Qiu Y; Zhang S; Xu B; Gao Y
Int J Pharm; 2013 Apr; 447(1-2):22-30. PubMed ID: 23410987
[TBL] [Abstract][Full Text] [Related]
4. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections.
Chen H; Li Y; Li L; Yang Z; Wen Z; Liu L; Liu H; Chen Y
Acta Biomater; 2023 Mar; 158():525-534. PubMed ID: 36572250
[TBL] [Abstract][Full Text] [Related]
5. Unprecedented Chiral Nanovaccines for Significantly Enhanced Cancer Immunotherapy.
Liu H; Xie Z; Zheng M
ACS Appl Mater Interfaces; 2022 Sep; 14(35):39858-39865. PubMed ID: 36007113
[TBL] [Abstract][Full Text] [Related]
6. Effect of liposomal formulations and immunostimulating peptidoglycan monomer (PGM) on the immune reaction to ovalbumin in mice.
Habjanec L; Frkanec R; Halassy B; Tomasić J
J Liposome Res; 2006; 16(1):1-16. PubMed ID: 16556546
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous ZnO nanocapsules for the induction of enhanced antigen-specific immunological responses.
Afroz S; Medhi H; Maity S; Minhas G; Battu S; Giddaluru J; Kumar K; Paik P; Khan N
Nanoscale; 2017 Oct; 9(38):14641-14653. PubMed ID: 28936523
[TBL] [Abstract][Full Text] [Related]
8. Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages.
Tanaka Y; Kasai M; Taneichi M; Naito S; Kato H; Mori M; Nishida M; Maekawa N; Yamamura H; Komuro K; Uchida T
Bioconjug Chem; 2004; 15(1):35-40. PubMed ID: 14733581
[TBL] [Abstract][Full Text] [Related]
9. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
10. An increased adjuvanticity of liposomes by the inclusion of phosphatidylserine in immunization with surface-coupled liposomal antigen.
Mori M; Nishida M; Maekawa N; Yamamura H; Tanaka Y; Kasai M; Taneichi M; Uchida T
Int Arch Allergy Immunol; 2005 Jan; 136(1):83-9. PubMed ID: 15591816
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol inclusion in liposomes affects induction of antigen-specific IgG and IgE antibody production in mice by a surface-linked liposomal antigen.
Nakano Y; Mori M; Yamamura H; Naito S; Kato H; Taneichi M; Tanaka Y; Komuro K; Uchida T
Bioconjug Chem; 2002; 13(4):744-9. PubMed ID: 12121129
[TBL] [Abstract][Full Text] [Related]
12. Enhanced desensitization efficacy by liposomal conjugation of a specific antigen.
Ichikawa K; Urakami T; Yonezawa S; Miyauchi H; Shimizu K; Asai T; Oku N
Int J Pharm; 2007 May; 336(2):391-5. PubMed ID: 17234372
[TBL] [Abstract][Full Text] [Related]
13. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.
Bal SM; Hortensius S; Ding Z; Jiskoot W; Bouwstra JA
Vaccine; 2011 Jan; 29(5):1045-52. PubMed ID: 21129393
[TBL] [Abstract][Full Text] [Related]
14. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
[TBL] [Abstract][Full Text] [Related]
15. Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response.
Brgles M; Habjanec L; Halassy B; Tomasić J
Vaccine; 2009 Sep; 27(40):5435-42. PubMed ID: 19632317
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant effect of cationic liposomes and CpG depends on administration route.
Slütter B; Bal SM; Ding Z; Jiskoot W; Bouwstra JA
J Control Release; 2011 Sep; 154(2):123-30. PubMed ID: 21315779
[TBL] [Abstract][Full Text] [Related]
17. Sublingual administration of liposomes enclosing alpha-galactosylceramide as an effective adjuvant of allergen immunotherapy in a murine model of allergic rhinitis.
Suzuki S; Sakurai D; Sakurai T; Yonekura S; Iinuma T; Okuma Y; Ihara F; Arai T; Hanazawa T; Fukuda-Kawaguchi E; Ishii Y; Okamoto Y
Allergol Int; 2019 Jul; 68(3):352-362. PubMed ID: 30803854
[TBL] [Abstract][Full Text] [Related]
18. Dual-adjuvant effect of pH-sensitive liposomes loaded with STING and TLR9 agonists regress tumor development by enhancing Th1 immune response.
Kocabas BB; Almacioglu K; Bulut EA; Gucluler G; Tincer G; Bayik D; Gursel M; Gursel I
J Control Release; 2020 Dec; 328():587-595. PubMed ID: 32971199
[TBL] [Abstract][Full Text] [Related]
19. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
[TBL] [Abstract][Full Text] [Related]
20. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
